Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02298348
Title Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium
Indications

neuroblastoma

Therapies

Cyclophosphamide + Sorafenib + Topotecan

Age Groups: adult | child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027-0700 United States Details
UCSF Comprehensive Cancer Center San Francisco California 94143 United States Details
Children Hospital of Colorado Aurora Colorado 80045 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
University of Chicago, Comer Children's Hospital Chicago Illinois 60637 United States Details
Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston Massachusetts 02115 United States Details
C.S Mott Children's Hospital Ann Arbor Michigan 48109 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 United States Details
Cook Children's Healthcare System Fort Worth Texas 76104 United States Details
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105 United States Details
Hospital for Sick Children Toronto Ontario M5G 1X8 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field